Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial page now displays the study record for pembrolizumab treatment of unresectable squamous cell carcinoma of the skin, including study design, eligibility, outcomes, investigators, and publication details.
    Difference
    47%
    Check dated 2026-11-08T02:05:35.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T21:04:15.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website transition updates and says the agency is changing its terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T22:15:22.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier advances from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T21:53:02.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T21:49:28.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study content for NCT02883556, indicating the record is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-19T20:48:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.